A Rare Case of Successful Management of Postpartum COVID-19-Related Coagulopathy

Pulmonary embolism, while a rare and life-threatening condition, is increasingly recognized in the context of pregnancy, particularly when compounded by infections such as coronavirus disease 2019 (COVID-19). This case report describes a 34-year-old pregnant woman, at 32 weeks of gestation, who developed COVID-19-related coagulopathy despite prophylactic treatment with low molecular weight heparin (LMWH). Admitted with symptoms of breathlessness, fever, and cough, she was diagnosed with COVID-19 and subsequently developed pulmonary embolism. This development was particularly unusual given her ongoing LMWH therapy. Diagnosis in such cases relies heavily on clinical assessment, evaluation of risk factors, and diagnostic tools, with computed tomography pulmonary angiography being pivotal for confirmation. This case highlights the complexities involved in managing COVID-19 among pregnant patients, especially the increased risk and diagnostic challenges associated with thromboembolic disorders. The successful resolution of the case, attributed to a multidisciplinary team's timely intervention and coordinated approach, emphasizes the critical need for prompt and individualized treatment strategies in similar clinical scenarios.